Company · CIK 0001419041 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Forte Biosciences, Inc. · FBRX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 27, 2026 UForm 4 → | Aug 27, 4:36 pm EDT | Steven KornfeldDirector | 3,960 | — | — | 0 | — | |
| Aug 27, 2026 UForm 4 → | Aug 27, 4:33 pm EDT | David W GryskaDirector | 5,940 | — | — | 0 | — | |
| Aug 27, 2026 UForm 4 → | Aug 27, 4:28 pm EDT | Antony A RileyCHIEF FINANCIAL OFFICER | 42,600 | — | — | 0 | — | |
| Aug 27, 2026 UForm 4 → | Aug 27, 4:28 pm EDT | Paul A. WagnerSEE REMARKS, Director | 85,482 | — | — | 0 | — | |
| Jul 1, 2026 FMForm 4 → | Jul 6, 4:04 pm EDT | Antony A RileyCHIEF FINANCIAL OFFICER | 509 | $21.32 | $2,857 | 42,600 | — | |
| Jul 1, 2026 FMForm 4 → | Jul 6, 4:03 pm EDT | Paul A. WagnerSEE REMARKS, Director | 1,348 | $21.32 | $2,089 | 85,482 | — | |
| Dec 8, 2017 JForm 4 → | Dec 14, 9:10 pm EST | Asha DasSVP & Chief Medical Officer | 2,500 | $8.50 | $21,250 | 5,000 | — | plan? late |
| Dec 8, 2017 JForm 4 → | Dec 14, 9:07 pm EST | Mark G FolettaEVP & Chief Financial Officer | 2,500 | $8.50 | $21,250 | 7,500 | — | plan? late |
| Dec 8, 2017 JForm 4 → | Dec 14, 9:02 pm EST | Martin J DuvallChief Executive Officer, Director | 2,500 | $8.50 | $21,250 | 6,071 | — | plan? late |
| Dec 8, 2017 JForm 4 → | Dec 14, 8:51 pm EST | Harry E GruberPresident, Research & Devel, Director | 2,500 | $8.50 | $21,250 | 2,500 | — | plan? late |
| Dec 8, 2017 JForm 4 → | Dec 14, 8:46 pm EST | Douglas JollyEVP, Research & Pharm Devel | 739 | $8.50 | $6,282 | 392,043 | — | plan? late |
| Apr 19, 2017 PForm 4 → | Apr 21, 5:44 pm EDT | Asha DasSVP & Chief Medical Officer | 2,500 | $10.00 | $25,000 | 2,500 | — | plan? |
| Apr 19, 2017 PForm 4 → | Apr 21, 5:42 pm EDT | Mark G FolettaEVP & Chief Financial Officer | 5,000 | $10.00 | $50,000 | 5,000 | — | plan? |
| Apr 19, 2017 PForm 4 → | Apr 21, 5:41 pm EDT | Harry E GruberPresident, Research & Devel, Director | 25,000 | $10.00 | $250,000 | 417,753 | +6.37% | plan? |
| Apr 19, 2017 JForm 4 → | Apr 21, 5:39 pm EDT | Martin J DuvallChief Executive Officer, Director | 3,571 | $10.00 | $35,710 | 3,571 | — | plan? |
| Apr 19, 2017 JForm 4 → | Apr 21, 5:37 pm EDT | Franklin M BergerDirector | 25,335 | $10.00 | $253,350 | 25,335 | — | plan? |
| Apr 19, 2017 PForm 4 → | Apr 21, 5:34 pm EDT | Paul SchimmelDirector | 10,000 | $10.00 | $100,000 | 13,623 | +276% | plan? |
| Apr 19, 2017 CForm 4 → | Apr 21, 5:34 pm EDT | Paul SchimmelDirector | 34,827 | — | — | 3,623 | — | plan? |
| Apr 19, 2017 PForm 4 → | Apr 21, 5:28 pm EDT | Faheem HasnainDirector | 100,000 | $10.00 | $1,000,000 | 202,857 | +97.2% | plan? |
| Apr 19, 2017 JForm 4 → | Apr 21, 5:28 pm EDT | Faheem HasnainDirector | 102,857 | $10.00 | $1,028,570 | 102,857 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 27, 2026 DForm 4 → | Aug 27, 4:36 pm EDT | Steven KornfeldDirector | 56,353 | — | — | 0 | — | |
| Aug 27, 2026 DForm 4 → | Aug 27, 4:34 pm EDT | Scott C. BrunDirector | 54,353 | — | — | 0 | — | |
| Aug 27, 2026 DForm 4 → | Aug 27, 4:33 pm EDT | David W GryskaDirector | 54,353 | — | — | 0 | — | |
| Aug 27, 2026 DForm 4 → | Aug 27, 4:32 pm EDT | Richard G VincentDirector | 51,353 | — | — | 0 | — | |
| Aug 27, 2026 DForm 4 → | Aug 27, 4:31 pm EDT | Barbara K FinckDirector | 60,519 | — | — | 0 | — | |
| Aug 27, 2026 DForm 4 → | Aug 27, 4:31 pm EDT | Shivpreet Singh KapoorDirector | 51,353 | — | — | 0 | — | |
| Aug 27, 2026 DForm 4 → | Aug 27, 4:30 pm EDT | Stephen K DobersteinDirector | 55,353 | — | — | 0 | — | |
| Aug 27, 2026 DForm 4 → | Aug 27, 4:28 pm EDT | Antony A RileyCHIEF FINANCIAL OFFICER | 520,845 | — | — | 0 | — | |
| Aug 27, 2026 DForm 4 → | Aug 27, 4:28 pm EDT | Paul A. WagnerSEE REMARKS, Director | 1,954,276 | — | — | 0 | — | |
| Jul 1, 2026 MForm 4 → | Jul 6, 4:04 pm EDT | Antony A RileyCHIEF FINANCIAL OFFICER | 375 | — | — | 750 | — | |
| Jul 1, 2026 MForm 4 → | Jul 6, 4:03 pm EDT | Paul A. WagnerSEE REMARKS, Director | 1,250 | — | — | 2,500 | — | |
| Jun 16, 2026 AForm 4 → | Jun 17, 4:55 pm EDT | Antony A RileyCHIEF FINANCIAL OFFICER | 22,000 | — | — | 22,000 | — | |
| Jun 16, 2026 AForm 4 → | Jun 17, 4:54 pm EDT | Paul A. WagnerSEE REMARKS, Director | 500,000 | — | — | 500,000 | — | |
| Mar 1, 2019 AForm 4 → | Mar 5, 6:06 pm EST | Mark G FolettaEVP & Chief Financial Officer | 75,000 | — | — | 75,000 | — | |
| Mar 1, 2019 AForm 4 → | Mar 5, 6:06 pm EST | Martin J DuvallChief Executive Officer, Director | 160,000 | — | — | 160,000 | — | |
| Mar 1, 2019 AForm 4 → | Mar 5, 6:04 pm EST | Douglas JollyEVP, Research & Pharm Devel | 25,000 | — | — | 25,000 | — | |
| Jan 11, 2019 AForm 4 → | Feb 26, 4:49 pm EST | Lori Anne KunkelActing-Chief Medical Officer | 35,000 | — | — | 35,000 | — | late |
| Jun 21, 2018 AForm 4 → | Jun 25, 4:55 pm EDT | Paul SchimmelDirector | 20,000 | — | — | 20,000 | — | |
| Jun 21, 2018 AForm 4 → | Jun 25, 4:51 pm EDT | David Ross ParkinsonDirector | 20,000 | — | — | 20,000 | — | |
| Jun 21, 2018 AForm 4 → | Jun 25, 4:48 pm EDT | Lori Anne KunkelDirector | 20,000 | — | — | 20,000 | — | |
| Jun 21, 2018 AForm 4 → | Jun 25, 4:43 pm EDT | Faheem HasnainDirector | 20,000 | — | — | 20,000 | — | |
| Jun 21, 2018 AForm 4 → | Jun 25, 4:39 pm EDT | Thomas E DarcyDirector | 20,000 | — | — | 20,000 | — | |
| Jun 21, 2018 AForm 4 → | Jun 25, 4:36 pm EDT | Franklin M BergerDirector | 20,000 | — | — | 20,000 | — | |
| Mar 1, 2018 AForm 4 → | Mar 2, 5:19 pm EST | Douglas JollyEVP, Research & Pharm Devel | 25,000 | — | — | 25,000 | — | |
| Mar 1, 2018 AForm 4 → | Mar 2, 5:17 pm EST | Mark G FolettaEVP & Chief Financial Officer | 85,000 | — | — | 85,000 | — | |
| Mar 1, 2018 AForm 4 → | Mar 2, 5:15 pm EST | Martin J DuvallChief Executive Officer, Director | 150,000 | — | — | 150,000 | — | |
| Mar 1, 2018 AForm 4 → | Mar 2, 5:13 pm EST | Asha DasSVP & Chief Medical Officer | 70,000 | — | — | 70,000 | — | |
| May 26, 2017 AForm 4 → | May 31, 9:13 pm EDT | Douglas JollyEVP, Research & Pharm Devel | 35,000 | — | — | 35,000 | — | |
| May 26, 2017 AForm 4 → | May 31, 9:12 pm EDT | Asha DasSVP & Chief Medical Officer | 130,000 | — | — | 130,000 | — | |
| May 26, 2017 AForm 4 → | May 31, 9:10 pm EDT | Harry E GruberPresident, Research & Devel, Director | 40,000 | — | — | 40,000 | — | |
| May 26, 2017 AForm 4 → | May 31, 9:08 pm EDT | Mark G FolettaEVP & Chief Financial Officer | 85,000 | — | — | 85,000 | — | |
| May 26, 2017 AForm 4 → | May 31, 8:34 pm EDT | Martin J DuvallChief Executive Officer, Director | 285,000 | — | — | 285,000 | — | |
| Apr 19, 2017 CForm 4 → | Apr 21, 5:34 pm EDT | Paul SchimmelDirector | 240,316 | — | — | 0 | — | |
| Apr 12, 2017 AForm 4 → | Apr 12, 9:09 pm EDT | Paul SchimmelDirector | 4,528 | — | — | 4,528 | — | |
| Apr 12, 2017 AForm 4 → | Apr 12, 9:08 pm EDT | Franklin M BergerDirector | 7,246 | — | — | 7,246 | — | |
| Apr 12, 2017 AForm 4 → | Apr 12, 9:06 pm EDT | David Ross ParkinsonDirector | 4,528 | — | — | 4,528 | — | |
| Apr 12, 2017 AForm 4 → | Apr 12, 9:05 pm EDT | Lori Anne KunkelDirector | 4,528 | — | — | 4,528 | — | |
| Apr 12, 2017 AForm 4 → | Apr 12, 9:04 pm EDT | Douglas JollyEVP, Research & Pharm Devel | 14,492 | — | — | 14,492 | — | |
| Apr 12, 2017 AForm 4 → | Apr 12, 9:02 pm EDT | Faheem HasnainDirector | 10,869 | — | — | 10,869 | — | |
| Apr 12, 2017 AForm 4 → | Apr 12, 9:00 pm EDT | Harry E GruberPresident, Research & Devel, Director | 27,536 | — | — | 27,536 | — | |
| Apr 12, 2017 AForm 4 → | Apr 12, 8:59 pm EDT | Martin J DuvallChief Executive Officer, Director | 46,739 | — | — | 46,739 | — | |
| Apr 12, 2017 AForm 4 → | Apr 12, 8:57 pm EDT | Asha DasSVP & Chief Medical Officer | 7,246 | — | — | 7,246 | — | |
| Apr 12, 2017 AForm 4 → | Apr 12, 8:55 pm EDT | Thomas E DarcyExecutive Vice President, Director | 4,528 | — | — | 4,528 | — |